Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kapil Dhingra, Sharon Terry, Ravi Bathina, More

Premium

Exosome Diagnostics has named Kapil Dhingra to be chairman of its board of directors. Dhingra has been a member of the board since March 2012.

He currently is member of KAPital Consulting, and he formerly was an executive at Hoffman La-Roche. He also worked at Eli Lilly and was a faculty member of the University of Texas MD Anderson Cancer Center.


The new personal genomics firm Mapmygenome India, which launched last week, has named Genetic Alliance President and CEO Sharon Terry to serve on its scientific advisory board, along with Ravi Bathina. The company also named its board of directors, including Arjun Malhotra, co-founder of HCL Technologies and founder of Headstrong; Anula Jayasuriya, co-founder and managing director of the Evolvence India Life Science Fund; company CEO Anu Acharya; and Subash Lingareddy, founder, president, and chief financial officer of Ocimum Biosolutions.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.